DEVELOMENT OF A CELL CULTURE SYSTEM FOR HIV INFECTION

Information

  • Research Project
  • 2073244
  • ApplicationId
    2073244
  • Core Project Number
    R43AI036770
  • Full Project Number
    1R43AI036770-01
  • Serial Number
    36770
  • FOA Number
    RFA-PH-S9-2S
  • Sub Project Id
  • Project Start Date
    8/1/1994 - 31 years ago
  • Project End Date
    1/31/1995 - 30 years ago
  • Program Officer Name
  • Budget Start Date
    8/1/1994 - 31 years ago
  • Budget End Date
    1/31/1995 - 30 years ago
  • Fiscal Year
    1994
  • Support Year
    1
  • Suffix
  • Award Notice Date
    7/29/1994 - 31 years ago

DEVELOMENT OF A CELL CULTURE SYSTEM FOR HIV INFECTION

Hepatitis E virus (HEV) is the major etiologic agent for enterically transmitted non-A, non-B hepatitis. Hepatitis E represents more than half of the acute viral hepatitis cases occurring in developing countries where large epidemics affect young to middle-aged adults. Systematic studies on HEV replication and pathogenesis are needed to guide diagnosis and prevention. No current method is available to grow HEV in culture. The overall goal of this proposal is to identify an in vitro infectious HEV molecule and to establish a cell culture system amenable to supporting viral replication. A full-length cDNA clone and in vitro-synthesized RNA transcripts of HEV will be tested for their respective abilities to infect susceptible cells in culture. To confirm in vitro infection, we will examine RNA- and DNA-transfected cells for the presence of replicative RNA species as well as authentic viral proteins. With the establishment of a cell culture system for HEV infection, we will, in future phase studies, investigate its potential utilities to provide useful reagents for the development of diagnostics and vaccine. It will also provide a model to study HEV cellular pathogenesis and thus potential ways to interfere with the process.

IC Name
NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES
  • Activity
    R43
  • Administering IC
    AI
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    856
  • Ed Inst. Type
  • Funding ICs
  • Funding Mechanism
  • Study Section
    ZRG7
  • Study Section Name
  • Organization Name
    GENELABS TECHNOLOGIES, INC.
  • Organization Department
  • Organization DUNS
  • Organization City
    REDWOOD CITY
  • Organization State
    CA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    940634737
  • Organization District
    UNITED STATES